Reliability of antioxidant potential and in vivo compatibility with extremophilic actinobacterial-mediated magnesium oxide nanoparticle synthesis.
Owing to the hazards of chemical and physical syntheses of magnesium oxide nanoparticles (MgO NPs), an eco-friendly, high-yield, and promising biological method is highly desirable for biomedical applications. Hence, in this study, an extremophilic actinobacterial population (SA8 and SA10) from Salem magnesite mining soil was used as precursors for MgO NP synthesis. The prepared nanoparticles were subjected to X-ray diffraction study and showed face-centred cubic structure with an average particle size of 18-24 nm. Among all, high yield was obtained in SA10 actinobacteria-mediated synthesis of MgO NPs (480 mg/100 mL). In addition, the prepared MgO NPs (10 mg/well) showed 15-17 mm zone of inhibition against bacterial pathogens, especially bigger zones around SA10. The 64.5% antioxidant activity and nonsignificant toxicity of actinobacteria-synthesized MgO NPs in MG-63 cell lines at 100 µg/mL and nonsignificant in vivo toxicity in zebrafish at 0.1 mg/mL were remarkable. In addition, this is the first study to focus on MgO NP synthesis using extremophilic actinobacteria collected from Salem magnesite mining soil for high yield (115 mg/100 mL), reliable with potential antioxidant, and in vitro and in vivo compatibility. These results provided useful information for advanced research and mass production of NP for biomedical applications.